oncology
CancerIQ provides personalized care plans to help providers detect cancer early and prevent progression of the disease, says Feyi Ayodele, founder and CEO of CancerIQ.
The company's diagnostics platform helps predict how patients will respond to immunotherapy.
Panelists at the Constellation Forum 2023 at Northwell Health discussed AI's impact on healthcare and how to adapt to the changing health tech environment.
The company will use the funds to enrich its technology, commercialize its MRD product and continue the development of its multi-cancer early detection offering.
Kimmel Comprehensive Cancer Care Center will be added to AccessHope's National Cancer Institute-Designated Comprehensive Cancer Center partner network.
The third-party administrator's employer members and their caregivers will have access to Jasper's oncology-focused support services.
The multinational pharma company will access Tempus' AI-enabled data library to further therapeutic development and advance its portfolio in oncology.
A study published in JAMA Network Open found that oncology care via telehealth was associated with time, travel and cost savings among cancer patients.
It plans to secure more regulatory approvals for its AI pathology platform.
Dr. Oliver Bleck, area head of Europe South at Roche, describes the pharma giant's work in personalized medicine.